SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000899923-22-000140
Filing Date
2022-11-02
Accepted
2022-11-02 16:08:00
Documents
86
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q mygn-20220930.htm   iXBRL 10-Q 1597479
2 EX-10.2 directorcompensationpolicy.htm EX-10.2 11309
3 EX-31.1 exhibit311-certificationof.htm EX-31.1 10543
4 EX-31.2 exhibit312-certificationof.htm EX-31.2 10559
5 EX-32.1 exhibit321-certificationpu.htm EX-32.1 6214
  Complete submission text file 0000899923-22-000140.txt   7658918

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT mygn-20220930.xsd EX-101.SCH 47301
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT mygn-20220930_cal.xml EX-101.CAL 81784
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT mygn-20220930_def.xml EX-101.DEF 222154
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT mygn-20220930_lab.xml EX-101.LAB 629319
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT mygn-20220930_pre.xml EX-101.PRE 400917
80 EXTRACTED XBRL INSTANCE DOCUMENT mygn-20220930_htm.xml XML 1421821
Mailing Address 320 WAKARA WAY SALT LAKE CITY UT 84108
Business Address 320 WAKARA WAY SALT LAKE CITY UT 84108 801-584-3600
MYRIAD GENETICS INC (Filer) CIK: 0000899923 (see all company filings)

IRS No.: 870494517 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-26642 | Film No.: 221354071
SIC: 2835 In Vitro & In Vivo Diagnostic Substances